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Abstract
Schwann cell myelination is tightly regulated by timely expression of key transcriptional
regulators that respond to specific environmental cues, yet molecular mechanisms underlying such
a process are poorly understood. Here, we report that HDAC1/2-regulated acetylation state of NF-
κB is critical in orchestrating the myelination program. Mice lacking HDAC1/2 exhibit severe
dysmyelination with Schwann cell development arrested at the immature stage. We find that NF-
κB p65 becomes heavily acetylated in HDAC1/2 mutants, inhibiting the expression of positive
regulators of myelination, while inducing the expression of differentiation inhibitors. We observe
that NF-κB protein complex switches its association with p300 to that with HDAC1/2 as Schwann
cells differentiate. NF-κB and HDAC1/2 act coordinately to regulate the transcriptionally-linked
chromatin state for Schwann cell myelination. Thus, our results reveal an HDAC-mediated
developmental switch for controlling myelination in the peripheral nervous system.
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Myelination of axons by Schwann cells in the peripheral nervous system (PNS) is essential
for axonal insulation and saltatory conduction of action potentials. Peripheral myelin defects
underlie various inherited or acquired demyelinating neuropathies in the PNS, leading to
motor and sensory disabilities 1. Schwann cell myelination is a well-characterized
developmental process, with a different set of regulators sequentially induced to play distinct
roles at discrete stages, until mature myelin is formed 2. Recent studies revealed a
transcriptional cascade that positively and negatively controls Schwann cell differentiation
in a spatiotemporally specific manner 2,3. Since expression of these factors is regulated by
different environmental cues, it is conceivable that epigenetic mechanisms play important
roles to instruct the myelination program. A well-studied chromatin remodeling is mediated
by histone methylation and acetylation, the latter being dynamically controlled by histone
acetyltransferases (HATs) and histone deacetylases (HDACs) 4. Recently, HDAC1 and
HDAC2 were shown to be essential for CNS myelination 5,6, however their function and
underlying mechanisms in Schwann cell differentiation and myelination remain elusive.
To define the role of HDAC1 and HDAC2 in Schwann cell development, we generated
HDAC single (HDAC1cKO or HDAC2cKO) and double HDAC1/2 mutants (dCKO,
HDAC1fl/fl;HDAC2fl/fl;DhhCre/+) mice, in which HDAC1/2 were deleted in the Schwann
cell lineage directed by Dhh-Cre 7. HDAC single mutants appeared normal as compared to
heterozygous control littermates, while dCKO mice developed severe tremors, hindlimb
paralysis and died around postnatal week 2 (Supplementary Fig. S1).
The sciatic nerves isolated from dCKO mice at P7 appeared much thinner and translucent
compared to the control and HDAC1 or 2 single mutants (Fig. 1a). Electron microscopy
ultrastructural analysis revealed that there was indeed severe myelin deficit in dCKO, and
majority of Schwann cells appeared to associate with multiple axon bundles, but without
forming myelin sheaths around axons (Fig. 1a). Similarly, at P0, the majority of Schwann
cells failed to establish a 1:1 relationship with individual axons although a few Schwann
cells were able to sort the axons (Fig. 1b). The absence of a discernable myelination defect
in HDAC1 or HDAC2 single mutants suggests that these HDACs function redundantly
during Schwann cell differentiation. Consistently, we observed upregulation of HDAC2 or
HDAC1 in HDAC1cKO or HDAC2cKO sciatic nerves, respectively (Fig. 1c), suggesting a
compensatory effect in each other's absence. Since HDAC1 or 2 single mutant phenotypes
were indistinguishable from heterozygous control, we focused on the control
(HDAC1fl/+;HDAC2fl/+;DhhCre/+) and dCKO for subsequent analyses. In line with the
electron microscopy analysis, in dCKO sciatic nerves, expression of mature myelin
components such as Mbp, Mag and Mpz was significantly downregulated (Fig. 2),
indicating a severe defect in Schwann cell differentiation. In contrast, the number of
immature Schwann cells expressing S100β and p75 was comparable to the control at P4
(Fig. 2a), and their proliferation was unaffected based on Ki67 expression and BrdU
incorporation (Supplementary Fig. 2a,b). There was a slight increase in the percentage of
apoptotic cells in the nerves (Supplementary Fig. 2c), however it did not alter the overall
number of immature Schwann cells. These results suggest that Schwann cell development
becomes arrested at the immature stage in the absence of HDAC1/2.
Since Schwann cell development is controlled by a series of positive and negative regulatory
factors 2,3, we next measured mRNA levels of these regulators. In dCKO sciatic nerves, we
observed not only a significant reduction in expression of positive regulators including Oct6/
SCIP/Pou3f1, Sox10, Krox20/Egr2 and GPR126, but also a concomitant increase in negative
regulators of Schwann cell differentiation such as Sox2, Sox11, Jagged1, c-Jun, Hes1, Hes5,
ID2 and ID4 (Fig. 2c). Protein levels of key Schwann cell differentiation regulators such as
Sox10, Oct6 and Krox20 were correlated with their mRNA levels assayed by qRT-PCR
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(Fig. 2b,c). These results suggest that HDAC1/2-dependent epigenetic modifications control
the overall transcriptional program to orchestrate proper Schwann cell differentiation.
Dysmyelination in dCKO sciatic nerves suggests that HDAC1/2 are likely to target critical
transcription factors for Schwann cell differentiation. As a candidate molecule, we focused
on NF-κB since it is crucial for Schwann cell differentiation by regulating expression of key
differentiation regulators such as Oct6 8, and in addition, its p65 subunit was known to
undergo a reversible acetylation/deacetylation by HATs (e.g. p300) and HDACs 9. Western-
blot analysis revealed that the amount of acetylated p65 dramatically increased in dCKO
sciatic nerves, while the total amount of p65 did not differ between control and dCKO at P4
(Fig. 3a). Consistently, we observed a robust increase in the expression intensity of
acetylated p65 in dCKO sciatic nerves via immunohistochemistry (Fig. 3b). Acetylated
tubulin levels did not increase in dCKO (Fig. 3a), suggesting that the effect of HDAC1/2
deletion on p65 acetylation was specific. Similarly to the lack of myelination defect, p65
acetylation levels were not altered in HDAC1 or HDAC2 single mutants (Supplementary
Fig. 3).
To determine the extent of p65 acetylation changes during the course of Schwann cell
development, we detected that the amount of acetylated p65 decreased gradually from P0 to
P14 (Fig. 3c). In addition, under the differentiation condition that promoted expression of
myelination-associated genes (Supplementary Fig. 4), the amount of p65 that interacted with
HDAC1 and 2 increased significantly in differentiating Schwann cells compared to
proliferating Schwann cells (Fig. 3d). On the other hand, the association of p65 with p300/
CBP, the major HAT for p65 acetylation 9, declined dramatically in differentiating Schwann
cells (Fig. 3d). Conversely, we observed an enhancement of acetyl p65/p300 interaction by
immunoprecipitation in myelin-deficient dCKO sciatic nerves (Fig. 3e). Together, these
results suggest that as Schwann cells differentiate, NF-κB p65 complex switches its
association with p300 to that with HDAC1/2, thereby undergoing deacetylation process.
Thus, these results identify the p65 subunit of NF-κB as a key substrate of HDAC1/2 in
regulating Schwann cell differentiation.
NF-κB p65 subunit is known to be acetylated at K310, K314, and K315, while K310
acetylation was reported to be critical for its transcriptional activity in vitro 10,11. To
determine whether the acetylation state of p65 regulates myelin gene transcription, we
introduced wildtype p65 and p65 mutants carrying mutations in the acetylation sites to
primary rat Schwann cells, along with reporters for differentiation activators or inhibitors.
Transfection of wildtype p65 substantially transactivated reporter activities of Sox10 or the
myelin gene Mpz (Fig. 4a), while inhibiting the ID4 or Hes5 promoter activity (Fig. 4b).
Overexpression of p65 acetylation mutants exhibited an enhanced ability to activate reporter
activities of Sox10 and Mpz promoters (Fig. 4a), and similarly caused a further decrease in
ID4 and Hes5 reporter activities (Fig. 4b). These results suggest that the acetylation state of
NF-κB p65 K310, K314 and K315 sites play a role in transcriptional control of the Schwann
cell myelination program.
We next tested whether introducing HDAC1/2 could mimic the effect of the p65 acetylation
mutations in primary Schwann cells. Indeed, combination of HDAC1/2 resulted in a 3-5-
fold increase in Sox10 and Mpz promoter activities (Fig. 4c), while it caused a 40%
reduction in ID4 promoter activity (Fig. 4d). Overexpression of p300 alone increased
endogenous p65 acetylation, which was further enhanced when introduced along with p65
(Fig. 4e). Strikingly, introduction of p300 substantially blocked endogenous expression of
Mbp and Sox10 with and without p65 in primary rat Schwann cells (Fig. 4f). In contrast to
the positive regulators of myelination, overexpression of p300 upregulated the expression of
differentiation inhibitors such as ID2, ID4, Notch effectors (Hes1, Hes5) as well as Notch
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signaling ligands (Jagged1, Delta1 and Delta3) 2,3 (Fig. 4g). Together, these results indicate
that HDAC-regulated deacetylation of NF-κB selectively activates expression of positive
regulators while repressing differentiation inhibitors to promote Schwann cell myelination.
Since HDAC1/2 are essential for gene transcription during Schwann cell myelination, we
hypothesized that the acetylation state of p65 regulated by HDACs may signal transcription-
dependent changes in chromatin structure. To address the hypothesis, we performed
chromatin immunoprecipitation assays with activating and repressive trimethyl histone
marks, H3K4me3 and H3K9me3 12,13, respectively, in addition to p65 and acetylated p65.
As for the target genes, we chose Schwann cell regulatory genes Sox10 and ID43 since both
contained a highly conserved NF-κB binding site in their promoter regions. In particular, the
Sox10 promoter carrying the NF-κB site was shown to direct reporter gene expression in
Schwann cells both in vivo and in vitro 14.
In control sciatic nerves, HDAC1, HDAC2 and p65 were recruited to the Sox10 promoter
region carrying the NF-κB binding site but not to the region that lack the NF-κB consensus
site (Fig. 5a). In contrast, in dCKO sciatic nerves, p65 recruitment was hardly detectable
while acetyl-p65 recruitment increased dramatically (Fig. 5a), which coincided with the
increase of p300 recruitment (Fig. 5a,b). Of particular interest is that robust recruitment of
an activating histone mark H3K4me3 to the promoter region observed in control was no
longer detected in dCKO. Instead, the recruitment of a repressive histone mark H3K9me3
increased significantly in dCKO (Fig. 5a,b). As a control, the recruitment level of H3K4me3
and H3K9me3 on a housekeeping gene GAPDH promoter was comparable between control
and dCKO sciatic nerves (Fig. 5c).
Within the ID4 promoter, on the other hand, the repressive mark H3K9me3 was robustly
recruited in control sciatic nerves, and H3K4me3 recruitment was barely detectable (Fig.
5d). Conversely, in the absence of HDAC1/2, H3K4me3 was strongly recruited along with
acetyl-p65 and p300, while H3K9me3 occupancy was significantly reduced (Fig. 5d,e).
Since trimethylation on histone H3-K4 and H3-K9 is the histone modification that is often
associated with gene activation and repression 12,13, respectively, our observations suggest
that HDAC1/2 channel through the acetylation state of NF-κB on the promoter region of
Schwann cell regulatory genes to induce a change of chromatin configuration in
coordination with transcriptional outcome. As a further support, introducing p65 into
Schwann cells isolated from dCKO sciatic nerves resulted in a significant increase in
expression of myelin genes and positive regulators of Schwann cell differentiation (Fig. 5f),
but a reduction of differentiation inhibitors (Fig. 5g). Thus, p65 overexpression could, at
least in part, rescue the defects of the Schwann cell differentiation program caused by the
loss of HDAC1/2, suggesting that p65 is a critical target of HDAC1/2 for Schwann cell
differentiation.
Requirement of HDACs for the formation of both myelinating oligodendrocytes and
Schwann cells suggests that HDAC1/2 have a conserved function in CNS and PNS
myelination by regulating common differentiation activators (e.g. Sox10 and YY1) and
inhibitors (e.g. ID4, Sox2 and Hes5) 6,15. However, HDACs may have divergent effects on
distinct signaling pathways and molecular targets in the CNS and PNS. We and others have
shown previously that HDAC1/2 regulate Wnt signaling 5, whose activation inhibits
myelination and remyelination in the CNS 5,16. Intriguingly, activation of canonical Wnt
signaling by β-catenin stabilization in the Schwann cell lineage did not affect Schwann cell
myelination in β-catenin activating mice (Catnlox(ex3)/+;DhhCre/+) (Fig. 6). There is a
potential discrepancy regarding Wnt/β-catenin activities in Schwann cell development
between our study and a companion study 17, in which HDAC1 was found to control
Schwann cell survival by regulating Wnt/β-catenin signaling 17. Although the reasons for
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the discrepancy is not clear, it might be due to potential differences in the cellular context
and timing.
In the PNS, NF-κB signaling is required for Schwann cell myelinogenesis 8. We show here
that HDAC1/2 control Schwann cell differentiation, at least in part, by modifying NF-κB
acetylation state and cooperating with NF-κB. At present, the role of NF-κB signaling in
CNS myelination is yet to be elucidated. Our data reveal a developmental switch of NF-κB
p65 complex with HATs e.g. p300 over to that with HDAC1/2 on target promoters during
Schwann cell differentiation (Supplementary Fig. 5). In addition, recruitment of chromatin
modifiers e.g. histone methyltransferases by HDACs and their effectors such as NF-κB may
also contribute to the specificity of target gene expression (Supplementary Fig. 5). Our
present study suggests that HDAC1/2 and NF-κB act coordinately to refine the epigenetic
landscape for gene transcription that is required for Schwann cell myelination. Enhancing
their activities may have therapeutic benefits for promoting myelin repair.
Methods
Generation of mice with HDAC1/2 mutant mice in the Schwann cell lineage
Mice carrying the HDAC1 and HDAC2 floxed alleles were bred with Schwann cell lineage
expressing Dhh-cre line 7, to generate HDAC1fl/fl;DhhCre/+(HDAC1CKO),
HDAC2fl/fl;DhhCre/+(HDAC2CKO), or HDAC1fl/fl;HDAC2fl/fl;DhhCre/+ (dCKO), and
control heterozygous (HDAC1fl/+;HDAC2fl/+;DhhCre/+) offspring. The control mice
developed and behaved the same as age-matched wild-type mice. Since HDAC1 or 2 single
mutant phenotypes were indistinguishable from heterozygous control, we mainly focused on
the control (HDAC1fl/+;HDAC2fl/+;DhhCre/+) and dCKO for subsequent analyses.
Conditional β-catenin activation (Catnlox(ex3)) 5,18 mice were generated by breeding with the
Dhh-Cre line to generate control (Catnlox(ex3)/+) and β-catenin activating mice
(Catnlox(ex3)/+;DhhCre/+), in which β-catenin is stabilized in the Schwann cell lineage. Dhh-
Cre-mediated excision of the exon 3 of the β-catenin allele produced a shortened, stable
form of β-catenin that lacks its N-terminal phosphorylation and ubiquitination sites,
resulting in constitutive activation of canonical Wnt signaling in the Schwann cell lineage.
Animal use and studies were approved by the Institutional Animal Care and Use Committee
of the University of Texas Southwestern Medical Center at Dallas.
Immunohistochemistry, electron microscopy and Western blot analysis
Sciatic nerves were fixed in 4% paraformaldehyde for 10 min, and then were embedded in
OCT, cut into 10-um as cross or longitudinal sections. For BrdU pulse labeling, animals at
P4 were injected intraperitoneally with 100 mg BrdU/kg body weight 2 hrs prior to sciatic
nerve collection. Primary antibodies were used: mouse anti-Mbp, anti-Mpz, anti-Mag
(Covance), rabbit anti-Krox20/Egr2 (Covance), goat anti-Oct6 (Santa Cruz), goat anti-
Sox10 (Abcam), mouse anti-BrdU (BD Biosciences), rabbit anti-Ki67 (Thermo Scientific),
rabbit anti-caspase 3 (Millipore), anti-p300/CBP (Santa Cruz), anti-NF-κB p65/RelA (Santa
Cruz) and anti-acetylated NF-κB p65 (acetyl K310) (Abcam). The acetyl-p65 antibody
detected NF-κB p65 acetylation at K310, the major acetylation site in p65. Currently, the
antibodies for NF-κB acetylated at K314 and K315 are not commercially available. Topro3
(Molecular probe) was used for cell nuclei stain. All images were acquired using Zeiss LSM
510 confocal microscope. For electron microscopy, sciatic nerves were dissected and fixed
in fixative solution containing 2% paraformaldehyde and 2% glutaraldehyde and 0.1M
cacodylic acid (pH7.2) and processed for electron microscopy. Western blot analysis was
performed according to the method described previously 19. GAPDH or tubulin was used as
an input control.
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qRT-PCR was carried out using the ABI Prism 7700 Sequence Detector System (Perkin-
Elmer Applied Biosystems) using Gapdh (TaqMan kit, Applied Biosystems) as an internal
as previously described 5. qPCR primers for mouse species: Mpz F: ctggtccagtgaatggtct, R:
gtcccttggcatagtggaaa; Mbp F: tcacagaagagaccctcaca, R: gccgtagtgggtagttcttg; OCT6
F:gttctcgcagaccaccatct, R: gtctcctccagccacttgtt; SOX10 F: agcccaggtgaagacagaga, R:
gtcaaactggggtcgtgag; Hes1 F: tctggaaatgactgtgaaca, R: gtcacctcgttcatgcactc; Hes5 F:
agctacctgaaacacagcaaagcc, R: taaagcagcttcatctgcgtgtcg; ID2 F: tgaacgactgctactccaagctca, R:
gtgctgcaggatttccatcttggt; ID4 F: gcagtgcgatatgaacgactgcta, R: taacgtgctgcaggatctccactt;
GPR126 F: ttatgtgagctgtgccgggtactt, R: attcctcccacagatctgcaccat; Gjb1 F:
ttcagaatcatggtgctggtggtg, R: accaagataagctgcagggaccat; Krox20 F: caggagtgacgaaaggaagc,
R: accagaggctgaagactgg; SOX2 F: cacaactcggagatcagcaa, R: ctccgggaagcgtgtactta; SOX11
F: gctggaagatgctgaaggac, R: gtcgggataatcagccatgt; C-Jun F: acccccactcagttcttgtg, R:
agttgctgaggttggcgtag; Jag-1 F: caaatgagtgcgaggccaaacctt, R: agccaggaaggcaatcacagtagt
qPCR primers for rat species: Mbp F: ttgactccatcgggcgcttcttta, R: gctgtgccacatgtacaaggatca;
SOX10 F: gctatccaggctcactacaag R: actgcagctctgtctttgg; ID2 F: atggaaatcctgcagcacgtcatc, R:
acgtttggttctgtccaggtctct; ID4 F: actgtgcctgcagtgcgatatgaa, R: tgcaggatctccactttgctgact; Hes1
F: agaaaaattcctcgtccccg, R: tttcatttattcttgcccggc; Hes5 F: accagcccaactccaaac, R:
agtaaccctcgctgtagtcc; Jag1 F: gactacgagggcaagaactg, R: gttggaagagatataccgcacc; Dll-1 F:
ttctctggcttcaactgtgag, R: tcatccacattgtcctcgc; Dll-3 F: attctatgggcctcgatgtgaggt, R:
aggatcttcaccgccaacacacaa
Primary Schwann cell culture and transfection
Rat Schwann cells were prepared from sciatic nerves of newborn rats (1–2 d old) as
described previously20. For routine culture, rat Schwann cells were grown under the
proliferation condition [DMEM (Gibco) with 10% fetal bovine serum (FBS) (Hyclone)
supplemented with 10 ng/ml neuregulin (R&D) and 5 μM forskolin (Sigma-Aldrich)]. Cells
between passages 2 and 4 were used in all experiments. To promote differentiation,
Schwann cells were cultured in a differentiation medium [DMEM with N2 (Gibco)
supplemented with 5 μM forskolin], resulting in a substantial increase of expression of
differentiation markers including Mpz and Krox20. Primary mouse Schwann cells were
prepared from sciatic nerves of newborn mice (P1) as described by Yeisr et al.21 and
cultured on poly-D-Lysine (Sigma) coated plate in DMEM (Gibco) with 10% fetal bovine
serum (FBS) (Hyclone) supplemented with 50ng/ml beta heregulin (EGF domain) (R&D
system). The primary Schwann cells were greater than 95% pure and used for transfection
study after isolation. For reporter assays, rat Schwann cells were transfected with luciferase
reporters and expression vectors using lipofectamine 2000. Transfected cells were cultured
for 48 hr before harvesting to measure the luciferase activity using luciferase assay kit
(Promega). The pRSV-renilla luciferase plasmid was included to control for variable
transfection efficiencies between different experiments (n ≥ 3 times).
Chromatin Immunoprecipitation (ChIP) assays
ChIP assay was performed as described 19. Briefly, sciatic nerves were dissected from
control and HDAC mutant mice and immediately fixed in 1% formaldehyde for 25 min at
room temperature. Nerves were washed in PBS, homogenized in 150mM NaCl, 10%
glycerol, 0.3% Triton X-100 and 50mM Tris-HCl (pH 8.0) containing protease inhibitor
cocktail (Roche) as described by Jang et al. 22. Lysates were then sonicated with a Bioruptor
sonicator (Diagenode) to ~500 bp. Sheared chromatin (~30 μg) was incubated with 2 μg of
anti-HDAC1, anti-HDAC2, anti-p65, anti-acetylated p65 K310, anti-trimethyl-histone3 K4
(Abcam), anti-trimethyl-histone3 K9 (Abcam) and anti-p300 (Abcam), respectively, for
each ChIP assay. Real-time PCR was carried out using quantitative SYBR green PCR mix
(Applied Biosystems, Inc.). The relative fold-enrichments were determined by the 2−ΔCT
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methods as previously described 23. Samples were normalized to input chromatin. Primers
used for ChIP-PCR analysis: Sox10 proximal promoter (−1/−176): Forward AGGCAGC
AGTGCGGGTCACA; Reverse: TGACTGAGCCGCTGCAGACG; Sox10
5′UTR(−900/−1140): Forward AATCATTGAGGCCTTGATTC; Reverse
CTCTACAGCCTAGTTAG TGT. ID4 promoter (−700/−493): Forward
ATTCCAGCCAGCA CATTCC; Reverse GGAGTGACCAGCCAATCAG; GAPDH
proximal promoter: Forward TTTGAAA TGTGCACGCACCAAGCG; Reverse
TGAGTCCTATCCTGGGAACCATCA.
Statistic analysis
Quantifications were performed from at least three experimental groups. Data are presented
as mean ± s.d. in the graphs. P values are from Student's two-tailed t test to compare two sets
of data. P value < 0.05 is considered to be statistically significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Ablation of HDAC1/2 in the Schwann cell lineage results in severe myelination defects
in sciatic nerves
(a) Appearance (upper panel) and electron microscopy analysis (lower panel, cross-section)
of sciatic nerves from control and HDAC1cKO, HDAC2cKO and dCKO mutants at P7. (b)
Electron microscopy analysis of cross sections of control and dCKO sciatic nerves at P0.
Inserts are shown for an individual sorted axon (arrows). Arrowheads indicate unsorted
axons. (c) Western blot analysis of HDAC1 and HDAC2 expression using sciatic nerves
from control, HDAC1cKO and HDAC2cKO at P4. GAPDH as a loading control. Full-length
blots/gels are presented in Supplementary Fig. 6. Scale bars in a, 1 mm (up panels) and 5 μm
(low panels); b, 5 μm.
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Figure 2. Effects of HDAC1/2 deletion on Schwann cell precursor formation and differentiation
(a) Cross sections of sciatic nerves of control and dCKO mice at P4 were immunostained
with antibodies to S100β and p75. Cell nuclei were counterstained with Topro3. Lower
panel, quantification of S100β+ or p75+ cells per cross-section. (b) Sciatic nerves of control
and dCKO mice at P5 were immunostained with antibodies with myelin components (cross-
sections) and transcriptional regulators (longitudinal sections) as indicated. (c) qRT-PCR
analysis of myelin-associated genes, promyelinating transcriptional regulators (upper panels)
and negative regulators (lower panels) in sciatic nerves of control and dCKO mice at P4 (*P
< 0.01). Scale bars in a, 60 μm; b, 40 μm.
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Figure 3. p65 subunit of NF-κB is a key substrate of HDAC1/2 for Schwann cell differentiation
(a) Lysates of control and dCKO sciatic nerves at P4 were subject to immunoblotting
analysis with antibodies to p65, acetyl-p65 K310 (Ac-p65), HDAC1, HDAC2, acetyl-
tubulin and tubulin as indicated. (b) Sciatic nerves of control and dCKO mice at P4 were
immunostained with antibodies to Mbp and acetyl p65. Cell nuclei were counterstained with
Topro3. (c) Western blot analysis of p65/RelA acetylation in wildtype sciatic nerves at P0,
P3, P7 and P14 with antibodies to acetyl p65 and GAPDH as indicated. (d) Lysates from
primary Schwann cells under the proliferation (Pro) and differentiation (Diff) condition for 4
days were co-immunoprecipitated (IP) with anti-p65 antibody and blotted with anti-HDAC1,
HDAC2, p300/CBP and GAPDH antibody, respectively. (e) Lysates of control and dCKO
sciatic nerves at P4 were immunoprecipitated with anti-p300 and blotted with anti-acetyl
p65. GAPDH as an input control. Full-length blots/gels are presented in Supplementary Fig.
6. Scale bars in b, 50 μm.
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Figure 4. The acetylation state of NF-κB regulated by HDAC1/2 is critical for the Schwann cell
differentiation program
(a-b) Primary rat Schwann cells were transfected with expressing vectors for p65, mutant
p65 carrying acetylation site mutation(s) and control vector pCMV (−), together with
luciferase reporters of Sox10- and Mpz-luc (a) and ID4- and Hes5-luc reporters (b),
respectively. (c-d) Primary rat Schwann cells were transfected with control and expressing
vectors for HDAC1, 2 or both together with luciferase reporters Sox10-luc and Mpz-luc (c)
or ID4-luc (d), respectively. (e) The lysates of primary Schwann cells transfected with
expression vectors for p65 and/or p300 were immunoblotted by anti-acetyl p65 and
GAPDH. Full-length blots/gels are presented in Supplementary Fig. 6. (f-g) Primary
Schwann cells were transfected with expressing vectors p65, p300 or both p65 and p300.
qRT-PCRs were performed to detect myelin associated genes Mbp and Sox10 (f), as well as
differentiation inhibitors ID2, ID4, Hes1, Hes5, Jagged1 (Jag1), Delta 1 (Dll1) and Delta 3
(Dll3) (g). Fold changes over controls were measured from three independent experiments in
a-d and f-g (n=3, *P < 0.01). Error bars shown are the mean ± s.d.
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Figure 5. HDAC1/2 and NF-κB cooperate to regulate epigenetic marks on the critical genes for
Schwann cell differentiation
(a) Upper panel, the conservation map of the Sox10 promoter among various vertebrates.
Lower panel, semi-quantitative ChIP-PCR assays for indicated protein/mark recruitment on
the Sox10 promoter from control and dCKO sciatic nerves at P5. NA, no antibody control.
(b) Quantification of enrichment of indicated protein/mark association with the Sox10
proximal promoter region by qRT-PCR. (n = 3; *P < 0.01). (c) qRT-PCR analysis of relative
enrichment of H3K4me3 and H3K9me3 marks on an active promoter of GAPDH in control
and dCKO SNs at P5. (d) Upper panel, the conservation map of the ID4 promoter among
various vertebrates. Lower panel, ChIP-PCR assays for protein recruitment on the promoter
of ID4 in control and dCKO SNs at P5. (e) qRT-PCR for enrichment of protein/marks on the
Sox10 proximal promoter region in control and dCKO sciatic nerves. Relative fold
enrichment in control versus dCKO sciatic nerves (b,c,e) was shown from three independent
experiments (n = 3; *P < 0.01). Blue lines in a, d; PCR amplification of promoter elements
with or without a NF-κB binding site (red dot) as indicted. (f-g) Primary Schwann cells
isolated from dCKO sciatic nerves at P1 were transfected with control and p65 expression
vectors and harvested 48 hrs after transfection. qRT-PCR was performed to detect
myelination associated genes Mpz, Mbp, Oct6 and Sox10 (f), as well as differentiation
inhibitory genes ID2, ID4, Hes1 and Hes5 (g) from three independent experiments (n = 3;
*P < 0.01).
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Figure 6. Activation of canonical Wnt/β-catenin signaling does not inhibit Schwann cell
myelination
(a) Electron microscopy of sciatic nerve cross-sections from control (Catnlox(ex3)) and Wnt/
β-catenin activating mice in the Schwann cell lineage (Catnlox(ex3)/+;DhhCre/+) at P15. (b)
The g-ratio (ratio of axon diameter/ myelinated fiber diameter) of the myelinated axons was
measured in sciatic nerves of control and β-catenin activating mice. Histogram presented the
percentage of counts for myelinated axons at the different range of g-ratio as mean ± s.d.
Scale bar, 5 μm.
Chen et al. Page 14
Nat Neurosci. Author manuscript; available in PMC 2011 October 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
